Pfizer Inc
Pfizer Inc reported 17 US-listed holdings worth $170.4 million in its 13F for the quarter ended 30 June 2026, filed 13 August 2026. Its largest: Allogene Therapeutics Inc. (27.5%), Celcuity Inc. (17.3%) and Arvinas Inc. (16.2%). Against the quarter before, it opened 0 positions, added to 0, trimmed 3 and sold out of 1.
The 14 largest of its 17 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned +40.4% over the 6 quarters to 30 June 2026, against +27.4% for the S&P 500.
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Trimmed 3
- Oric Pharmaceuticals Inc. ORIC-4.4 million shares · -92%
- Zura Bio Ltd ZURA-2.3 million shares · -81%
- Nextcure Inc. NXTC-109,007 shares · -71%
Sold out of 1
- Q32 Bio Inc. QTTB$736,731 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Allogene Therapeutics Inc. ALLO | 22.0M | $46.9 million | 27.55% | no change |
| Celcuity Inc. CELC | 295.7K | $29.6 million | 17.35% | no change |
| Arvinas Inc. ARVN | 3.5M | $27.7 million | 16.24% | no change |
| Pyxis Oncology Inc. PYXS | 7.0M | $19.5 million | 11.43% | no change |
| Wave Life Sciences Ltd WVE | 1.9M | $10.9 million | 6.42% | no change |
| Biohaven Ltd BHVN | 505.6K | $8.0 million | 4.70% | no change |
| Caribou Biosciences Inc. CRBU | 4.7M | $7.9 million | 4.63% | no change |
| Spero Therapeutics Inc SPRO | 2.4M | $5.3 million | 3.13% | no change |
| Zentalis Pharmaceuticals Inc. ZNTL | 953.8K | $3.9 million | 2.26% | no change |
| Oric Pharmaceuticals Inc. ORIC | 372.9K | $3.6 million | 2.09% | -4.4M |
| Cardiff Oncology Inc. CRDF | 2.4M | $3.0 million | 1.77% | no change |
| Zura Bio Ltd ZURA | 538.8K | $2.9 million | 1.69% | -2.3M |
| Agomab Therapeutics NV AGMB | 75.0K | $1.0 million | 0.61% | no change |
| Bolt Biotherapeutics Inc. BOLT | 31.3K | $133,832 | 0.08% | no change |
| Nextcure Inc. NXTC | 44.3K | $72,967 | 0.04% | -109.0K |
| Ginkgo Bioworks Holdings Inc DNA | 2.9K | $30,012 | 0.02% | no change |
| Senseonics Hldgs Inc. | 2.2K | $12,418 | 0.01% | no change |